{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:04:47Z","timestamp":1793228687405,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10120-025-01702-x","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T11:39:54Z","timestamp":1767785994000},"page":"347-356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Long-term use of potassium-competitive acid blockers and proton pump inhibitors and the risk of metachronous gastric cancer after H. pylori eradication: a multicenter cohort study"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7784-6210","authenticated-orcid":false,"given":"Yasutoshi","family":"Shiratori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobumi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoku","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Kiyotoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Sumiyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenkei","family":"Hasatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hutfless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Niikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"1702_CR1","unstructured":"The global, regional, and national burden of stomach cancer in 195 countries, 1990\u20132017: a systematic analysis for the Global Burden of Disease study 2017. Lancet Gastroenterol Hepatol. 2020;5:42\u201354."},{"key":"1702_CR2","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.1016\/S2468-2667(25)00044-1","volume":"10","author":"Three decades of population health changes in Japan","year":"2025","unstructured":"Three decades of population health changes in Japan. 1990\u20132021: a subnational analysis for the global burden of disease study 2021. Lancet Public Health. 2025;10:e321\u201332.","journal-title":"Lancet Public Health"},{"key":"1702_CR3","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s10120-021-01183-8","volume":"24","author":"S Abe","year":"2021","unstructured":"Abe S, Takizawa K, Oda I, Mizusawa J, Kadota T, Ono H, et al. Incidence and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection of undifferentiated-type early gastric cancer: Japan clinical oncology group study-post hoc analysis of JCOG1009\/1010. Gastric Cancer. 2021;24:1123\u201330.","journal-title":"Gastric Cancer"},{"key":"1702_CR4","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/apt.13121","volume":"41","author":"H Jenkins","year":"2015","unstructured":"Jenkins H, Sakurai Y, Nishimura A, Okamoto H, Hibberd M, Jenkins R, et al. Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects. Aliment Pharmacol Ther. 2015;41:636\u201348.","journal-title":"Aliment Pharmacol Ther"},{"key":"1702_CR5","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/apt.13325","volume":"42","author":"Y Sakurai","year":"2015","unstructured":"Sakurai Y, Mori Y, Okamoto H, Nishimura A, Komura E, Araki T, et al. Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects\u2013a randomised open-label cross-over study. Aliment Pharmacol Ther. 2015;42:719\u201330.","journal-title":"Aliment Pharmacol Ther"},{"key":"1702_CR6","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1053\/j.gastro.2024.06.038","volume":"167","author":"A Patel","year":"2024","unstructured":"Patel A, Laine L, Moayyedi P, Wu J. AGA clinical practice update on integrating potassium-competitive acid blockers into clinical practice: expert review. Gastroenterology. 2024;167:1228\u201338.","journal-title":"Gastroenterology"},{"key":"1702_CR7","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1097\/MS9.0000000000000874","volume":"85","author":"D Suto","year":"2023","unstructured":"Suto D, Yoshida M, Otake T, Osawa Y, Sato K, Yamada H, et al. Anti-acid treatment for ulcerated early gastric cancer may be a treatment option avoiding unnecessary gastrectomy: a cohort study. Ann Med Surg. 2023;85:3269\u201372.","journal-title":"Ann Med Surg"},{"key":"1702_CR8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/1751-2980.12813","volume":"20","author":"C Liu","year":"2019","unstructured":"Liu C, Feng BC, Zhang Y, Li LX, Zuo XL, Li YQ. The efficacy of vonoprazan for management of post-endoscopic submucosal dissection ulcers compared with proton pump inhibitors: a meta-analysis. J Dig Dis. 2019;20:503\u201311.","journal-title":"J Dig Dis"},{"key":"1702_CR9","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00464-018-6409-4","volume":"33","author":"EH Kim","year":"2019","unstructured":"Kim EH, Park SW, Nam E, Lee JG, Park CH. Comparative efficacy of various anti-ulcer medications after gastric endoscopic submucosal dissection: a systematic review and network meta-analysis. Surg Endosc. 2019;33:1271\u201383.","journal-title":"Surg Endosc"},{"key":"1702_CR10","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1159\/000507807","volume":"102","author":"T Ishida","year":"2021","unstructured":"Ishida T, Dohi O, Yamada S, Yasuda T, Yamada N, Tomie A, et al. Clinical outcomes of vonoprazan-treated patients after endoscopic submucosal dissection for gastric neoplasms: a prospective multicenter observation study. Digestion. 2021;102:386\u201396.","journal-title":"Digestion"},{"key":"1702_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.gie.2021.06.032","volume":"95","author":"Y Shiratori","year":"2022","unstructured":"Shiratori Y, Niikura R, Ishii N, Ikeya T, Honda T, Hasatani K, et al. Vonoprazan versus proton pump inhibitors for postendoscopic submucosal dissection bleeding in the stomach: a multicenter population-based comparative study. Gastrointest Endosc. 2022;95:72-9.e3.","journal-title":"Gastrointest Endosc"},{"key":"1702_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-021-01781-4","author":"H Abe","year":"2021","unstructured":"Abe H, Hatta W, Ogata Y, Koike T, Saito M, Jin X, et al. Prevention of delayed bleeding with vonoprazan in upper gastrointestinal endoscopic treatment. J Gastroenterol. 2021. https:\/\/doi.org\/10.1007\/s00535-021-01781-4.","journal-title":"J Gastroenterol"},{"key":"1702_CR13","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1056\/NEJMoa1708423","volume":"378","author":"IJ Choi","year":"2018","unstructured":"Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med. 2018;378:1085\u201395.","journal-title":"N Engl J Med"},{"key":"1702_CR14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1053\/j.gastro.2023.10.013","volume":"166","author":"HW Yoo","year":"2024","unstructured":"Yoo HW, Hong SJ, Kim SH. Helicobacter pylori treatment and gastric cancer risk after endoscopic resection of dysplasia: a nationwide cohort study. Gastroenterology. 2024;166:313-22.e3.","journal-title":"Gastroenterology"},{"key":"1702_CR15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.5056\/jnm25024","volume":"31","author":"HS Choi","year":"2025","unstructured":"Choi HS, Kim MS, Yu MH, You J, Seon D, Ko G, et al. Long-term effects of potassium-competitive acid blockers and proton pump inhibitors on gastrin, gastric emptying rate, and small intestinal microbiota in rats. J Neurogastroenterol Motil. 2025;31:384\u201395.","journal-title":"J Neurogastroenterol Motil"},{"key":"1702_CR16","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/gut.2010.207662","volume":"60","author":"T Hagiwara","year":"2011","unstructured":"Hagiwara T, Mukaisho K, Nakayama T, Sugihara H, Hattori T. Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori. Gut. 2011;60:624\u201330.","journal-title":"Gut"},{"key":"1702_CR17","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.2169\/internalmedicine.2857-23","volume":"63","author":"S Nagao","year":"2024","unstructured":"Nagao S, Yabuuchi Y, Tanaka K, Morihisa Y, Kobayashi T, Akiyama S, et al. Multiple gastric neuroendocrine tumors associated with long-term use of a proton pump inhibitor and a potassium-competitive acid blocker. Intern Med. 2024;63:2001\u201310.","journal-title":"Intern Med"},{"key":"1702_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/gutjnl-2017-314605","volume":"67","author":"KS Cheung","year":"2018","unstructured":"Cheung KS, Chan EW, Wong AYS, Chen L, Wong ICK, Leung WK. Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study. Gut. 2018;67:28\u201335.","journal-title":"Gut"},{"key":"1702_CR19","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/apt.17676","volume":"58","author":"EJ Gong","year":"2023","unstructured":"Gong EJ, Jung HK, Lee B, Hong J, Kim JW, Shin CM, et al. Proton pump inhibitor use and the risk of metachronous gastric cancer after H. pylori eradication in patients who underwent endoscopic resection for gastric neoplasms: a population-based cohort study. Aliment Pharmacol Ther. 2023;58:668\u201377.","journal-title":"Aliment Pharmacol Ther"},{"key":"1702_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.5946\/ce.2023.279","volume":"57","author":"K Kubo","year":"2024","unstructured":"Kubo K, Kimura N, Kato M. Potassium-competitive acid blocker-associated gastric mucosal lesions. Clin Endosc. 2024;57:417\u201323.","journal-title":"Clin Endosc"},{"key":"1702_CR21","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.cgh.2024.01.037","volume":"22","author":"J Arai","year":"2024","unstructured":"Arai J, Miyawaki A, Aoki T, Niikura R, Hayakawa Y, Fujiwara H, et al. Association between vonoprazan and the risk of gastric cancer after helicobacter pylori eradication. Clinic Gastroenterol Hepatol: Offic Clinic pr J Am Gastroenterol Assoc. 2024;22:1217-25.e6.","journal-title":"Clinic Gastroenterol Hepatol: Offic Clinic pr J Am Gastroenterol Assoc"},{"key":"1702_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"1702_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.5946\/ce.2015.049","volume":"49","author":"JY Lee","year":"2016","unstructured":"Lee JY, Min BH, Lee JG, Noh D, Lee JH, Rhee PL, et al. Endoscopic submucosal dissection for early gastric neoplasia occurring in the remnant stomach after distal gastrectomy. Clin Endosc. 2016;49:182\u20136.","journal-title":"Clin Endosc"},{"key":"1702_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4143\/crt.2010.42.4.217","volume":"42","author":"JH Kim","year":"2010","unstructured":"Kim JH, Rha SY, Kim C, Kim GM, Yoon SH, Kim KH, et al. Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites. Cancer Res Treat. 2010;42:217\u201324.","journal-title":"Cancer Res Treat"},{"key":"1702_CR25","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1159\/000515213","volume":"102","author":"Y Okamoto","year":"2021","unstructured":"Okamoto Y, Kanzaki H, Tanaka T, Sakae H, Abe M, Iwamuro M, et al. Gastric adenoma: a high incidence rate of developing carcinoma and risk of metachronous gastric cancer according to long-term follow-up. Digestion. 2021;102:878\u201386.","journal-title":"Digestion"},{"key":"1702_CR26","doi-asserted-by":"publisher","first-page":"646","DOI":"10.5009\/gnl20036","volume":"15","author":"GH Kim","year":"2021","unstructured":"Kim GH. Proton pump inhibitor-related gastric mucosal changes. Gut Liver. 2021;15:646\u201352.","journal-title":"Gut Liver"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-025-01702-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-025-01702-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-025-01702-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T07:35:38Z","timestamp":1781422538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10120-025-01702-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1702"],"URL":"https:\/\/doi.org\/10.1007\/s10120-025-01702-x","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest related to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}